Cat. No. | Product name | CAS No. |
DC40842 |
Mal-amino-sulfo
Mal-amino-sulfo is an alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs. |
158018-81-6 |
DC40858 |
BSJ-04-132
BSJ-04-132 is a potent and selective Ribociclib-based CDK4 degrader (PROTAC), with IC50s of 50.6 nM and 30 nM for CDK4/D1 and CDK6/D1, respectively. BSJ-04-132 does not induce CDK6 and IKZF1/3 degradation. BSJ-04-132 has anti-cancer activity. |
2349356-39-2 |
DC41044 |
PROTAC KRASG12C Degrader-LC-2
PROTAC KRASG12C Degrader-LC-2 is a potent and first-in-class degrader of endogenous KRAS G12C with DC50 values between 0.25 and 0.76 μM. PROTAC KRASG12C Degrader-LC-2 is composed of a covalent KRAS G12C inhibitor MRTX849, a VHL ligand and a linker. |
|
DC41057 |
L-Azidohomoalanine hydrochloride
L-Azidohomoalanine hydrochloride is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs. |
942518-29-8 |
DC41138 |
N-Boc-piperazine
N-Boc-piperazine is a Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTAC PD-1/PD-L1 degrader-1. |
57260-71-6 |
DC41141 |
endo-BCN-O-PNB
endo-BCN-O-PNB is an alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs. |
1263166-91-1 |
DC42085 |
Br-C3-methyl ester
Br-C3-methyl ester is a Alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTAC PD-1/PD-L1 degrader-1. |
4897-84-1 |
DC42099 |
Maleimide-C10-NHS ester
Maleimide-C10-NHS ester is an alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs. |
87981-04-2 |
DC39826 |
Homo-PROTAC cereblon degrader 1
Featured
Homo-PROTAC cereblon degrader 1, is a cereblon degrader. |
2244520-98-5 |
DC42433 |
CP5V
CP5V is a PROTAC, which specifically degrades Cdc20 by linking Cdc20 to the VHL/VBC complex for ubiquitination followed by proteasomal degradation. CP5V induces mitotic inhibition and suppresses cancer cell proliferation. |
2509359-75-3 |
DC42434 |
PROTAC IDO1 Degrader-1
PROTAC IDO1 Degrader-1 is the first potent IDO1 (indoleamine 2,3-dioxygenase 1) degrader that hijacks IDO1 to CRBN E3 ligase to introduce IDO1 into UPS and eventually achieve ubiquitination and degradation (DC50=2.84 μM). PROTAC IDO1 Degrader-1 moderately improves the tumor-killing activity of H ER2 CAR-T cells. |
2488851-89-2 |
DC42435 |
LC-2
Featured
LC-2 is a potent and first-in-class degrader of endogenous KRAS G12C with DC50 values between 0.25 and 0.76 μM. LC-2 covalently binds KRAS G12C with a MRTX849 warhead and recruits the E3 ligase VHL, inducing rapid and sustained KRAS G12C degradation leading to suppression of MAPK signaling in both homozygous and heterozygous KRAS G12C cell lines. |
2502156-03-6 |
DC43998 |
Tos-O-C4-NH-Boc
Tos-O-C4-NH-Boc is an alkyl ether-based PROTAC linker can be used in the synthesis of PROTACs, such as BSJ-03-204 |
180851-50-7 |
DC51010 |
CID 138454799
Featured
ERD-308 is a highly potent PROTAC degrader of estrogen receptor (ER) for ER positive breast cancer treatment. |
2320561-35-9 |
DC44010 |
BOC-NH-PEG2-propene
BOC-NH-PEG2-propene is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. |
2410236-85-8 |
DC44011 |
Propenyl-PEG3-Propenyl
Propenyl-PEG3-Propenyl is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. |
90736-68-8 |
DC44014 |
H2N-PEG2-CH2COOtBu
H2N-PEG2-CH2COOtBu is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. |
1122484-77-8 |
DC44016 |
Benzyl-PEG2-acid
Benzyl-PEG2-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. |
91555-65-6 |
DC44022 |
Hydroxy-PEG4-methyl acetate
Hydroxy-PEG4-methyl acetate is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. |
77303-64-1 |
DC44024 |
Boc-NH-PEG-Thiol (MW 10000)
Boc-NH-PEG-Thiol (MW 10000) is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. |
|
DC44025 |
m-PEG750-Br
m-PEG750-Br is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. |
|
DC44026 |
NH2-PEG-Strt (MW 10000)
NH2-PEG-Strt (MW 10000) is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. |